For the patient’s prognosis, the results show that CENPA contributes to the worse outcome of bladder cancer in both GSE5287 and TCGA-BLCA (Fig. 5C, D and Figure S3A-B) datasets. The gene discussed is CENPA; the disease is bladder transitional cell carcinoma.